U.S. Other Utilities Stock News

If you are wondering whether Navient is priced attractively right now, the recent share moves and current valuation metrics give you quite a bit to think about. The stock recently closed at US$9.81, with returns of an 18.8% decline over 7 days, a 24.5% decline over 30 days, a 23.2% decline year to date and a 24.7% decline over the past year, alongside a 41.1% decline over 3 years and a 3.2% decline over 5 years. These moves have been unfolding against a backdrop of ongoing market attention...

Lyft (LYFT) has drawn fresh investor attention after appointing transportation safety veteran Deborah Hersman to its Board and Nominating and Corporate Governance Committee, a governance shift closely tied to safety and autonomous mobility plans. See our latest analysis for Lyft. The appointment of Hersman comes as Lyft’s share price has faced pressure, with a 1 month share price return of a 12.91% decline and a 90 day share price return of a 17.55% decline. At the same time, the 1 year total...

Royal Gold (RGLD) is back on many investors’ screens after recent share price swings, including a 10% decline over the past week and solid gains over the month and past 3 months. See our latest analysis for Royal Gold. At a share price of $263.31, Royal Gold’s recent 10% weekly pullback sits alongside a 30 day share price return of 18.45% and a 90 day share price return of 50.64%. Its 1 year total shareholder return of 90.14% and 5 year total shareholder return of 164.46% point to strong...

Halliburton (NYSE:HAL) has launched the Next-Generation Energy Accelerators Joint Lab, known as NEX Lab, in collaboration with A*STAR in Singapore. The joint lab is focused on advanced well completion technologies and supporting energy transition efforts. NEX Lab is intended to expand research, engineering, and testing capabilities while supporting local talent development and low carbon solutions. For investors watching NYSE:HAL, this move comes with the stock at $33.52 and a 30 day return...

Sun Pharmaceutical has submitted a nonbinding offer to acquire Organon (NYSE:OGN). Organon recently received FDA approval for extended duration use of NEXPLANON with a new REMS safety program. These developments affect Organon’s women’s health portfolio and potential ownership structure. Organon, trading at $8.54, is coming into focus as both a deal target and a women’s health player with a newly approved product label. The share price is up 19.1% over the past 30 days and 18.0% year to...

Yum! Brands stock overview Yum! Brands (YUM) has been drawing attention after recent share price moves, with the stock last closing at $155.50. For context, the company reports annual revenue of $8.06b and net income of $1.45b. See our latest analysis for Yum! Brands. Yum! Brands’ share price has been relatively steady in the short term, while a 12.51% 90 day share price return and 21.46% one year total shareholder return suggest momentum has been building over a longer horizon. If this kind...

Managed care stocks sold off after a minimal proposed Medicare Advantage rate hike and weaker guidance from several large insurers. In this context, Elevance Health (NYSE:ELV) reported Q4 and full year results and issued a cautious 2026 outlook that points to cost pressure in Medicaid and operating margins. Management outlined plans focused on portfolio repositioning, tighter execution and targeted investments, while signaling an aim for stronger earnings growth from 2027. For Elevance...

United Parcel Service (UPS) stock is in focus after the company moved to sharply cut lower margin deliveries for Amazon, pairing that reset with job reductions and cost savings across its global network. See our latest analysis for United Parcel Service. Those Amazon cuts and cost actions sit against a mixed share price story, with a 30 day share price return of 7.09% and 90 day share price return of 10.16%, but a 1 year total shareholder return of 0.62% decline. This suggests recent momentum...

Eli Lilly (NYSE:LLY) is committing $3.5 billion to build a new manufacturing facility in Pennsylvania focused on next generation weight loss drugs, including retatrutide. The company has also entered alliances with Repertoire Immune Medicines on autoimmune therapies and Seamless Therapeutics on gene editing approaches for hearing loss. These moves expand Eli Lilly's U.S. production footprint and broaden its pipeline beyond GLP-1 based treatments. Eli Lilly, trading at $1,037.15 per share,...

Cheniere Energy, Inc. recently announced that its Board of Directors declared a quarterly cash dividend of US$0.555 per common share, payable on February 27, 2026 to shareholders of record as of February 6, 2026. This dividend decision underscores how Cheniere is using cash from its large U.S. LNG export platform and expansion projects to return capital to shareholders while it continues to invest across the LNG value chain. With this fresh dividend declaration highlighting Cheniere’s...

TETRA Technologies (TTI) has drawn fresh attention after a strong share price move over the past month and the past three months, prompting investors to reassess its valuation and recent financial profile. See our latest analysis for TETRA Technologies. That recent share price run, including a 21.66% 30 day share price return and 61.47% 90 day share price return to US$11.40, sits alongside a very strong 1 year total shareholder return of 174.70% and a 5 year total shareholder return above 4x...

If you are wondering whether Newmont is priced attractively today, the recent share moves and current valuation metrics give you plenty to think about. The stock last closed at US$112.35, with a 7 day return of a 9.6% decline, contrasted against gains of 12.5% over 30 days, 11.0% year to date, 167.5% over 1 year and 144.4% over 3 years. Recent coverage of Newmont has focused on how investors are reassessing large gold producers and their role in portfolios, which helps frame these strong...

Viavi Solutions (VIAV) has just posted Q2 2026 results with revenue of US$369.3 million and a basic EPS loss of US$0.21, while trailing twelve month figures show revenue of US$1.2 billion and a basic EPS loss of US$0.19. Over recent quarters, the company has seen revenue move from US$270.8 million in Q2 2025 to US$369.3 million in Q2 2026, with EPS shifting from a profit of US$0.04 to a loss of US$0.21 as margins compressed. See our full analysis for Viavi Solutions. With the latest numbers...

In recent weeks, ClearBridge Investments exited its position in Corpay Inc., citing new uncertainty around how emerging stablecoin technologies could affect parts of the company’s corporate payments business. At the same time, Corpay Lodging expanded its 2 million-hotel global network to U.S. companies and upgraded its workforce travel platform, highlighting a contrast between product expansion and institutional concern over technological disruption. We’ll now examine how ClearBridge’s exit...

Silicom (SILC) closed FY 2025 with Q4 revenue of US$16.9 million and a basic EPS loss of US$0.44, alongside net income excluding extra items of a US$2.5 million loss, putting another loss-making quarter on the scoreboard. Over recent periods the company has seen quarterly revenue move from US$14.5 million in Q4 2024 through US$14.4 million in Q1 2025, US$15.0 million in Q2, and US$15.6 million in Q3. Quarterly basic EPS stayed in loss territory, ranging from a US$1.05 loss per share in Q4...

In late January 2026, Meta Platforms reported fourth-quarter 2025 results that exceeded expectations, with US$59.89 billion in sales and US$22.77 billion in net income, and guided first-quarter 2026 revenue to US$53.5 billion–US$56.5 billion. The company paired this earnings beat with plans to lift 2026 capital expenditures to US$115 billion–US$135 billion for AI infrastructure, signalling a major shift in how it allocates cash between shareholder returns and long-term technology...

Vera Therapeutics (NasdaqGM:VERA) has appointed Matt Skelton as Chief Commercial Officer. The move comes as the company prepares for potential commercialization of its lead drug, atacicept, for IgA nephropathy. Atacicept has received Breakthrough Therapy Designation and Priority Review from the FDA. Vera Therapeutics focuses on therapies for serious immunologic diseases, with atacicept as its lead asset in IgA nephropathy. The addition of a Chief Commercial Officer signals that management...

Snap has created a wholly-owned subsidiary, Specs Inc., to develop and launch its first consumer augmented reality smart glasses, separating the venture from the core Snapchat app and allowing use without a Snapchat account. By ring‑fencing Specs with its own operations, partnerships, and potential capital structure, Snap is carving out a focused AR computing business that can be evaluated independently of its social media platform. We’ll now examine how this separation of Specs into an...

Recent performance context for SLB (SLB) SLB (SLB) has drawn investor interest after a strong run over the past month and the past 3 months, with the stock up about 26% and 34% respectively, against a last close of $48.38. See our latest analysis for SLB. That recent surge sits on top of a year to date share price return of 20.35% and a 1 year total shareholder return of 23.91%. The 5 year total shareholder return of 115.35% shows the longer term picture has been strong, even though the 3...

Recent industry attention on eToro Group has focused on how upcoming regulatory changes, including MiFID II amendments, DORA enforcement and a Payment-for-Order-Flow ban, are set to redefine operating standards for digital brokerage platforms. These shifts are expected to raise the bar on transparency, resilience and data connectivity, offering larger players such as eToro an opportunity to deepen user engagement and reinforce trust through stronger compliance and richer account aggregation...

In late January 2026, Delta Air Lines announced a major order for 31 Airbus A330-900 and A350-900 widebody jets, with options for 20 more, to refresh and expand its long-haul international fleet from 2029 onward while keeping its existing financial guidance unchanged. This long-dated, largely pre-financed fleet modernization underscores Delta’s intent to deepen its premium long-haul offering and sharpen its competitive position in global markets. We’ll now examine how this widebody fleet...

AGNC Investment (NasdaqGS:AGNC) reported robust full-year economic returns for 2025. The company continued its high-yield monthly dividend policy, keeping the payout in double-digit territory. Management outlined a more cautious capital deployment and selective investment approach for 2026. The shift is linked to changing mortgage market conditions, including tighter spreads and prepayment risks. AGNC Investment (NasdaqGS:AGNC) focuses on mortgage backed securities, so shifts in mortgage...

If you are trying to figure out whether Kraft Heinz is priced attractively right now, starting with how the current share price lines up against its fundamentals can be a useful first step. The stock recently closed at US$23.74, with returns of 2.3% over 7 days, a 2.1% decline over 30 days, a 2.7% decline year to date, and a 15.7% decline over 1 year, while the 3 year and 5 year returns stand at 30.0% and 11.4% declines respectively. Recent attention on Kraft Heinz has centered on how a well...

Global Ship Lease recently reported quarterly results that surpassed earnings expectations, reinforcing its reputation for consistent operational execution while the container shipping sector remains supportive. Despite this performance, the company continues to trade on relatively low valuation multiples against peers, drawing increased attention from value-focused investors who see its rising earnings estimates as a potential mismatch with its current market pricing. With these...